Literature DB >> 28437312

Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer.

Yuichiro Nakashima1, Hiroshi Saeki, Ryota Nakanishi, Masahiko Sugiyama, Junji Kurashige, Eiji Oki, Yoshihiko Maehara.   

Abstract

OBJECTIVE: The objective of the study was to elucidate the impact of sarcopenia in elderly patients with esophageal cancer on postoperative complications and long-term survival after surgery for esophageal cancer. SUMMARY BACKGROUND DATA: Sarcopenia, defined as loss of skeletal muscle mass with age, has been identified as a poor prognostic factor for malignancies. This retrospective study investigated the effect of sarcopenia on surgical outcomes among young and elderly patients with esophageal cancer.
METHODS: Data were collected for 341 consecutive patients who underwent esophagectomy for esophageal cancer. Patients were assigned to 2 groups according to age (younger than 65 years and 65 years or older) and the presence of sarcopenia.
RESULTS: Sarcopenia was present in 170 of 341 patients (49.9%) with esophageal cancer and in 74 of 166 elderly patients (44.6%). The incidence of anastomotic leak and in-hospital death was significantly higher in the elderly sarcopenia group than in the elderly nonsarcopenia group (31.5% vs 15.2%, P = 0.015, 6.8 vs 0.0%, P = 0.037, respectively), and the overall survival rate in patients with sarcopenia correlated with a significantly poor prognosis in the elderly group (P < 0.001). Multivariate analysis revealed that sarcopenia was a risk factor for an anastomotic leak (P = 0.034) and was an unfavorable prognostic factor for survival (P < 0.001). Those correlations between sarcopenia and surgical outcomes were not observed in the young group.
CONCLUSIONS: Sarcopenia and worse surgical outcomes were significantly associated patients with in esophageal cancer aged 65 years and older but not in those younger than 65 years.

Entities:  

Mesh:

Year:  2018        PMID: 28437312     DOI: 10.1097/SLA.0000000000002252

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  40 in total

Review 1.  Recent progress in perioperative management of patients undergoing esophagectomy for esophageal cancer.

Authors:  Masayuki Watanabe; Akihiko Okamura; Tasuku Toihata; Kotaro Yamashita; Masami Yuda; Masaru Hayami; Ian Fukudome; Yu Imamura; Shinji Mine
Journal:  Esophagus       Date:  2018-04-25       Impact factor: 4.230

2.  Predictive Value of Preoperative Sarcopenia in Patients with Gastric Cancer: a Meta-analysis and Systematic Review.

Authors:  Zhengdao Yang; Xin Zhou; Bin Ma; Yanan Xing; Xue Jiang; Zhenning Wang
Journal:  J Gastrointest Surg       Date:  2018-07-09       Impact factor: 3.452

3.  Sarcopenia is Associated with Nonunion of Open Tibia and Ankle Fractures.

Authors:  Wyatt Vander Voort; John Davison; Nathan Hendrickson; Joseph Buckwalter; Brian Guetschow; Natalie Glass; Michael Willey
Journal:  Iowa Orthop J       Date:  2020

4.  Sarcopenia and Short-Term Outcomes After Esophagectomy: A Meta-analysis.

Authors:  Pei-Yu Wang; Li-Dong Xu; Xian-Kai Chen; Lei Xu; Yong-Kui Yu; Rui-Xiang Zhang; Hai-Bo Sun; Hui-Li Wu; Yin Li
Journal:  Ann Surg Oncol       Date:  2020-02-10       Impact factor: 5.344

5.  Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving Chemoradiotherapy.

Authors:  Sho Sato; Chikara Kunisaki; Hideaki Suematsu; Yusaku Tanaka; Hiroshi Miyamoto; Takashi Kosaka; Norio Yukawa; Kuniya Tanaka; Kei Sato; Hirotoshi Akiyama; Itaru Endo
Journal:  In Vivo       Date:  2018 May-Jun       Impact factor: 2.155

6.  Sarcopenia does not affect postoperative complication rates in oesophageal cancer surgery: a systematic review and meta-analysis.

Authors:  D Schizas; M Frountzas; I Lidoriki; E Spartalis; K Toutouzas; D Dimitroulis; T Liakakos; K S Mylonas
Journal:  Ann R Coll Surg Engl       Date:  2019-09-11       Impact factor: 1.891

7.  Opportunistic body composition evaluation in patients with esophageal adenocarcinoma: association of survival with 18F-FDG PET/CT muscle metrics.

Authors:  Cathy Zhou; Brent Foster; Rosalie Hagge; Cameron Foster; Leon Lenchik; Abhijit J Chaudhari; Robert D Boutin
Journal:  Ann Nucl Med       Date:  2019-12-10       Impact factor: 2.668

8.  Decreases in the Psoas Muscle Index Correlate More Strongly with Survival than Other Prognostic Markers in Esophageal Cancer After Neoadjuvant Chemoradiotherapy Plus Esophagectomy.

Authors:  Yuta Kawakita; Satoru Motoyama; Yusuke Sato; Akiyuki Wakita; Yushi Nagaki; Kazuhiro Imai; Yoshihiro Minamiya
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

9.  A novel prognostic marker in patients with non-small cell lung cancer: musculo-immuno-nutritional score calculated by controlling nutritional status and creatine kinase.

Authors:  Shinkichi Takamori; Gouji Toyokawa; Mototsugu Shimokawa; Fumihiko Kinoshita; Yuka Kozuma; Taichi Matsubara; Naoki Haratake; Takaki Akamine; Fumihiko Hirai; Tetsuzo Tagawa; Yoshinao Oda; Yoshihiko Maehara
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

10.  Prognostic Significance of Preoperative Osteopenia in Patients Undergoing Esophagectomy for Esophageal Cancer.

Authors:  Keita Takahashi; Katsunori Nishikawa; Kenei Furukawa; Yuichiro Tanishima; Yoshitaka Ishikawa; Takanori Kurogochi; Masami Yuda; Yujiro Tanaka; Akira Matsumoto; Norio Mitsumori; Toru Ikegami
Journal:  World J Surg       Date:  2021-06-21       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.